Inhibitory effects of a novel antiatheromatous agent, E5050, an aortic smooth muscle cell proliferation, in vitro
- 31 July 1990
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 189 (1) , 23-29
- https://doi.org/10.1016/0922-4106(90)90226-n
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effects of smooth muscle cell derived growth factor (SDGF) in combination with other growth factors on smooth muscle cellsAtherosclerosis, 1989
- Possible involvement of protein kinase C in platelet-derived growth factor-stimulated DNA synthesis in vascular smooth muscle cellsAtherosclerosis, 1987
- Involvement of three intracellular messenger systems, protein kinase C, calcium ion and cyclic AMP, in the regulation of c‐fos gene expression in Swiss 3T3 cellsFEBS Letters, 1986
- Early Signals in the Mitogenic ResponseScience, 1986
- Increased platelet-derived mitogenic activity in plasma of young patients with coronary atherosclerosisAtherosclerosis, 1986
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Involvement of Ca2+ in platelet‐derived growth factor‐induced expression of c‐myc oncogene in Swiss 3T3 fibroblastsFEBS Letters, 1985
- Is epidermal growth factor present in human blood? Interference with the radioreceptor assay for epidermal growth factorBiochemical and Biophysical Research Communications, 1983
- Platelet‐derived growth factor is a chemoattractant for vascular smooth muscle cellsJournal of Cellular Physiology, 1982
- Atherosclerosis and the Arterial Smooth Muscle CellScience, 1973